Betta Pharmaceuticals Co., Ltd. (SHE:300558)

Betta Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Market Capitalization	28,555	22,569	21,573	20,525	33,154	44,361
Market Cap Growth	25.20%	4.62%	5.11%	-38.09%	-25.26%	68.38%
Enterprise Value	30,433	24,170	23,045	20,899	31,905	43,858
Last Close Price	67.87	53.76	51.15	48.82	78.66	105.47
PE Ratio	69.95	56.06	61.99	141.14	86.55	73.16
Forward PE	37.38	29.63	42.25	65.91	49.20	99.01
PS Ratio	9.29	7.80	8.78	8.64	14.76	23.72
PB Ratio	5.07	3.98	4.03	4.14	7.08	10.70
P/TBV Ratio	11.69	9.47	7.45	6.38	11.18	14.20
P/FCF Ratio	112.07	270.04	-	-	-	-
P/OCF Ratio	29.70	24.77	23.60	66.91	62.96	68.67
PEG Ratio	-	3.08	3.08	3.08	3.08	3.08
EV/Sales Ratio	9.90	8.36	9.38	8.79	14.21	23.45
EV/EBITDA Ratio	31.94	28.60	39.86	46.08	61.61	76.95
EV/EBIT Ratio	54.02	50.68	82.34	100.98	91.48	105.74
EV/FCF Ratio	119.44	289.20	-	-	-	-
Debt / Equity Ratio	0.42	0.42	0.45	0.21	0.00	0.00
Debt / EBITDA Ratio	2.50	2.82	4.17	2.27	0.02	0.00
Debt / FCF Ratio	9.37	28.67	-	-	-	-
Asset Turnover	0.33	0.31	0.29	0.34	0.39	0.40
Inventory Turnover	1.82	1.74	1.16	0.81	0.72	0.86
Quick Ratio	0.36	0.38	0.58	0.59	1.36	3.64
Current Ratio	0.62	0.66	0.85	0.82	1.86	4.22
Return on Equity (ROE)	6.91%	7.03%	6.47%	2.59%	8.60%	18.18%
Return on Assets (ROA)	3.82%	3.23%	2.05%	1.82%	3.79%	5.54%
Return on Capital (ROIC)	4.38%	3.76%	2.54%	2.42%	4.93%	7.14%
Return on Capital Employed (ROCE)	8.00%	6.40%	3.80%	3.60%	6.50%	8.70%
Earnings Yield	1.42%	1.78%	1.61%	0.71%	1.16%	1.37%
FCF Yield	0.89%	0.37%	-0.84%	-3.43%	-0.70%	-0.09%
Dividend Yield	0.29%	0.37%	0.33%	0.14%	0.32%	0.29%
Payout Ratio	39.35%	37.48%	31.69%	95.94%	35.93%	19.74%
Buyback Yield / Dilution	0.47%	-0.01%	-0.72%	0.02%	-2.32%	-1.09%
Total Shareholder Return	0.76%	0.37%	-0.39%	0.16%	-2.00%	-0.80%

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.